Dachaigh › Luchd-obrach › Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Lyell Immunopharma, Inc. 8 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 8. Tuarastal meadhanach a chaidh a thabhann: $181,171.
A bheil Lyell Immunopharma, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Lyell Immunopharma, Inc. 8 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 6 Gearr 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Sr. Director, Total Rewards | 2 | $236,639 |
| Sr. Business Analyst, Financial Systems | 2 | $160,682 |
| Clinical Data Platform Product Manager | 1 | $200,000 |
| Senior Scientist, Translational Pathology Laboratory | 1 | $144,000 |
| Scientist II | 1 | $160,169 |
| Senior Director, Medical Affairs, Solid Tumors | 1 | $291,304 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 3 | $195,500 |
| FY2024 | 2 | $177,262 |
| FY2025 | 2 | $152,084 |
| FY2026 | 1 | $291,304 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Compensation and Benefits Managers2
- Computer Systems Analysts2
- Computer and Information Systems Managers1
- Medical Scientists, Except Epidemiologists1
- Molecular and Cellular Biologists1
- Natural Sciences Managers1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior Director, Medical Affairs, Solid Tumors | $291,304–$330,000 Ìre IV | Redwood City, CA | 6 Gearr 2026 | 23 Màrt 2026 | Dearbhaichte |
| Scientist II | $160,169–$173,000 | South San Francisco, CA | 12 Ògmh 2025 | 12 Ògmh 2025 | Dearbhaichte |
| Senior Scientist, Translational Pathology Laboratory | $144,000–$216,000 Ìre III | South San Francisco, CA | 12 Samh 2024 | 15 Gearr 2025 | Dearbhaichte, an uair sin air a tharraing air ais |
| Sr. Business Analyst, Financial Systems | $154,523–$180,000 Ìre IV | South San Francisco, CA | 10 Gibl 2023 | 6 Iuch 2023 | Dearbhaichte, an uair sin air a tharraing air ais |
| Sr. Director, Total Rewards | $195,500–$280,000 Ìre IV | South San Francisco, CA | 10 Faoi 2023 | 20 Faoi 2023 | Dearbhaichte |
| Sr. Business Analyst, Financial Systems | $166,842 Ìre IV | South San Francisco, CA | 5 Faoi 2023 | 6 Iuch 2023 | Dearbhaichte |
| Sr. Director, Total Rewards | $277,778 E-3 · Ìre IV | South San Francisco, CA | 21 Samh 2022 | 16 Dùbh 2022 | Dearbhaichte |
| Clinical Data Platform Product Manager | $200,000 Ìre III | Seattle, WA | 30 Lùna 2021 | 6 Sult 2021 | Dearbhaichte, an uair sin air a tharraing air ais |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).